Number of the records: 1  

Dual effect of anandamide on spinal nociceptive transmission in control and inflammatory conditions

  1. 1.
    SYSNO ASEP0583846
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleDual effect of anandamide on spinal nociceptive transmission in control and inflammatory conditions
    Author(s) Pontearso, Monica (FGU-C) ORCID
    Slepička, Jakub (FGU-C) ORCID
    Bhattacharyya, Anirban (FGU-C) RID, SAI, ORCID
    Špicarová, Diana (FGU-C) RID, ORCID
    Paleček, Jiří (FGU-C) RID, ORCID
    Article number116369
    Source TitleBiomedicine & Pharmacotherapy. - : Elsevier - ISSN 0753-3322
    Roč. 173, April (2024)
    Number of pages11 s.
    Languageeng - English
    CountryNL - Netherlands
    Keywordsanandamide ; CB1 ; TRPV1 ; FAAH ; spinal cord ; synaptic transmission
    OECD categoryNeurosciences (including psychophysiology
    R&D ProjectsGA21-02371S GA ČR - Czech Science Foundation (CSF)
    GA18-09853S GA ČR - Czech Science Foundation (CSF)
    LX22NPO5104 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportFGU-C - RVO:67985823
    UT WOS001203663600001
    EID SCOPUS85187184399
    DOI10.1016/j.biopha.2024.116369
    AnnotationAnandamide (AEA) is an important modulator of nociception in the spinal dorsal horn, acting presynaptically through Cannabinoid (CB1) and Transient receptor potential vanilloid (TRPV1) receptors. The role of AEA (1 µM, 10 µM, and 30 µM) application on the modulation of nociceptive synaptic transmission under control and inflammatory conditions was studied by recording miniature excitatory postsynaptic currents (mEPSCs) from neurons in spinal cord slices. Inhibition of the CB1 receptors by PF514273, TRPV1 by SB366791, and the fatty acid amide hydrolase (FAAH) by URB597 was used. Under naïve conditions, the AEA application did not affect the mEPSCs frequency (1.43±0.12 Hz) when all the recorded neurons were considered. The mEPSC frequency increased (180.0±39.2%) only when AEA (30 µM) was applied with PF514273 and URB597. Analysis showed that one sub-population of neurons had synaptic input inhibited (39.1% of neurons), the second excited (43.5%), whereas 8.7% showed a mixed effect and 8.7% did not respond to the AEA. With inflammation, the AEA effect was highly inhibitory (72.7%), while the excitation was negligible (9.1%), and 18.2% were not modulated. After inflammation, more neurons (45.0%) responded even to low AEA by mEPSC frequency increase with PF514273/URB597 present. AEA-induced dual (excitatory/inhibitory) effects at the 1st nociceptive synapse should be considered when developing analgesics targeting the endocannabinoid system. These findings contrast the clear inhibitory effects of the AEA precursor 20:4-NAPE application described previously and suggest that modulation of endogenous AEA production may be more favorable for analgesic treatments.
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2025
    Electronic addresshttps://doi.org/10.1016/j.biopha.2024.116369
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.